Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment [0.03%]
代谢健康和心血管代謝风险亚型：对预测、预防和治疗的启示
Norbert Stefan,Matthias B Schulze
Norbert Stefan
Among 20 leading global risk factors for years of life lost in 2040, reference forecasts point to three metabolic risks-high blood pressure, high BMI, and high fasting plasma glucose-as being the top risk variables. Building upon these and ...
Srikanth Bellary,Anthony H Barnett
Srikanth Bellary
Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial [0.03%]
每周一次胰岛素icodec与每日一次德谷胰岛素治疗2型糖尿病受试者的一项IIIa期、随机、开放标签、多中心、靶向治疗试验（ONWARDS 2）
Athena Philis-Tsimikas,Marisse Asong,Edward Franek et al.
Athena Philis-Tsimikas et al.
Background: Insulin icodec (icodec) is a once-weekly basal insulin currently under development. ONWARDS 2 aimed to assess the efficacy and safety of once-weekly icodec versus once-daily insulin degludec (degludec) in basa...
The PEN-Plus Partnership: addressing severe chronic non-communicable diseases among the poorest billion [0.03%]
PEN-PLUS伙伴关系：解决最底层10亿人群严重慢性非传染性疾病问题
Gene Bukhman,Ana Mocumbi,Emily Wroe et al.
Gene Bukhman et al.
Effect of COVID-19 restrictions on thyroid cytopathology: delay in the diagnosis of indeterminate lesions [0.03%]
COVID-19限制对甲状腺细胞病理学的影响：不确定病变诊断的延迟
Esther Diana Rossi,Liron Pantanowitz
Esther Diana Rossi
Effect of the COVID-19 pandemic on surgery for indeterminate thyroid nodules (THYCOVID): a retrospective, international, multicentre, cross-sectional study [0.03%]
一项关于新冠肺炎疫情对甲状腺不确定结节手术影响的回顾性国际多中心横断面研究（THYCOVID）
Fabio Medas,Chiara Dobrinja,Ebtesam Abdullah Al-Suhaimi et al.
Fabio Medas et al.
Background: Since its outbreak in early 2020, the COVID-19 pandemic has diverted resources from non-urgent and elective procedures, leading to diagnosis and treatment delays, with an increased number of neoplasms at advan...
Talha Burki
Talha Burki
Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry [0.03%]
一项关于1型糖尿病供体胰岛同种异基因移植后原发移植物功能与5年预后的回顾性、多中心、观察队列研究：来自胰岛移植协作注册中心的1210例患者数据
Mikaël Chetboun,Elodie Drumez,Cassandra Ballou et al.
Mikaël Chetboun et al.
Background: Allogeneic islet transplantation is a validated therapy in type 1 diabetes; however, there is decline of transplanted islet graft function over time and the mechanisms underlying this decline are unclear. We e...
Observational Study
The lancet. Diabetes & endocrinology. 2023 Jun;11(6):391-401. DOI:10.1016/S2213-8587(23)00082-7 2023